{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:57:06Z","timestamp":1781279826401,"version":"3.54.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["FONDECYT Regular 1220433"],"award-info":[{"award-number":["FONDECYT Regular 1220433"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Beyond the development of resistance, the effects of antibiotics on bacteria and microbial communities are complex and far from exhaustively studied. In the context of the current global antimicrobial resistance crisis, understanding the adaptive and physiological responses of bacteria to antimicrobials is of paramount importance along with the development of new therapies. Bacterial dependence on antibiotics is a phenomenon in which antimicrobials instead of eliminating the pathogens actually provide a boost for their growth. This trait comprises an extreme example of the complexities of responses elicited by microorganisms to these drugs. This compelling evolutionary trait was readily described along with the first wave of antibiotics use and dependence to various antimicrobials has been reported.  Nevertheless, current molecular characterizations have been focused on dependence on vancomycin, linezolid and colistin, three critically important antibiotics frequently used as last resource therapy for multi resistant pathogens. Outstanding advances have been made in understanding the molecular basis for the dependence to vancomycin, including specific mutations involved. Regarding linezolid and colistin, the general physiological components affected by the dependence, namely ribosomes and membrane function respectively, have been established. Nonetheless the implications of antibiotic dependence in clinically relevant features, such as virulence, epidemics, relationship with development of resistance, diagnostics and therapy effectiveness require clarification. This review presents a brief introduction of the phenomenon of bacterial dependence to antibiotics and a summary on early and current research concerning the basis for this trait. Furthermore, the available information on the effect of dependence in key clinical aspects is discussed. The studies performed so far underline the need to fully disclose the biological and clinical significance of this trait in pathogens to successfully assess its role in resistance and to design adjusted therapies.<\/jats:p>","DOI":"10.1186\/s12929-023-00963-x","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T03:08:07Z","timestamp":1691982487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fierce poison to others: the phenomenon of bacterial dependence on antibiotics"],"prefix":"10.1186","volume":"30","author":[{"given":"Claudia C.","family":"Paredes-Amaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-4726","authenticated-orcid":false,"given":"V\u00edctor Antonio","family":"Garc\u00eda-Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"963_CR1","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10:S122\u20139.","journal-title":"Nat Med"},{"key":"963_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00820-y","author":"EM Darby","year":"2022","unstructured":"Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2022. https:\/\/doi.org\/10.1038\/s41579-022-00820-y.","journal-title":"Nat Rev Microbiol"},{"key":"963_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/antibiotics2020237","volume":"2","author":"F Corona","year":"2013","unstructured":"Corona F, Martinez JL. Phenotypic resistance to antibiotics. Antibiotics (Basel). 2013;2:237\u201355.","journal-title":"Antibiotics (Basel)"},{"key":"963_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","author":"JM Munita","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015.","journal-title":"Microbiol Spectr."},{"key":"963_CR5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2217\/fmb-2019-0324","volume":"15","author":"M Wenzel","year":"2020","unstructured":"Wenzel M. Do we really understand how antibiotics work? Future Microbiol. 2020;15:1307\u201311.","journal-title":"Future Microbiol"},{"key":"963_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00902-5","author":"F Sanz-Garc\u00eda","year":"2023","unstructured":"Sanz-Garc\u00eda F, Gil-Gil T, Laborda P, Blanco P, Ochoa-S\u00e1nchez L-E, Baquero F, et al. Translating eco-evolutionary biology into therapy to tackle antibiotic resistance. Nat Rev Microbiol. 2023. https:\/\/doi.org\/10.1038\/s41579-023-00902-5.","journal-title":"Nat Rev Microbiol"},{"key":"963_CR7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-121-1-199407010-00004","volume":"121","author":"HS Fraimow","year":"1994","unstructured":"Fraimow HS, Jungkind DL, Lander DW, Delso DR, Dean JL. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med. 1994;121:22\u20136.","journal-title":"Ann Intern Med"},{"key":"963_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.23838\/pfm.2017.00184","volume":"1","author":"KS Ko","year":"2017","unstructured":"Ko KS, Choi Y, Lee J-Y. Old drug, new findings: colistin resistance and dependence of Acinetobacter baumannii. Precis Future Med. 2017;1:159\u201367.","journal-title":"Precis Future Med"},{"key":"963_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3201\/eid1901.111527","volume":"19","author":"S Pournaras","year":"2013","unstructured":"Pournaras S, Ntokou E, Zarkotou O, Ranellou K, Themeli-Digalaki K, Stathopoulos C, et al. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates. Emerg Infect Dis. 2013;19:129\u201332.","journal-title":"Emerg Infect Dis"},{"key":"963_CR10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(96)24049-8","volume":"348","author":"N Farrag","year":"1996","unstructured":"Farrag N, Eltringham I, Liddy H. Vancomycin-dependent Enterococcus faecalis. Lancet. 1996;348:1581\u20132.","journal-title":"Lancet"},{"key":"963_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3181\/00379727-64-15808","volume":"64","author":"WH Hall","year":"1947","unstructured":"Hall WH, Spink WW. In vitro sensitivity of Brucella to streptomycin; development of resistance during streptomycin treatment. Proc Soc Exp Biol Med. 1947;64:403\u20136.","journal-title":"Proc Soc Exp Biol Med"},{"key":"963_CR12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.106.2763.587","volume":"106","author":"T Kushnick","year":"1947","unstructured":"Kushnick T, Randles CI, Gray CT, Birkeland JM. Variants of Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis requiring streptomycin. Science. 1947;106:587\u20138.","journal-title":"Science"},{"key":"963_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/jb.54.4.467-481.1947","volume":"54","author":"CP Miller","year":"1947","unstructured":"Miller CP, Bohnhoff M. Two streptomycin-resistant variants of Meningococcus 1. J Bacteriol. 1947;54:467\u201381.","journal-title":"J Bacteriol"},{"key":"963_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/jb.56.2.207-218.1948","volume":"56","author":"TF Paine","year":"1948","unstructured":"Paine TF, Finland M. Observations on bacteria sensitive to, resistant to, and dependent upon streptomycin. J Bacteriol. 1948;56:207\u201318.","journal-title":"J Bacteriol"},{"key":"963_CR15","first-page":"56","volume":"116","author":"CR Schi\u00f8tt","year":"1954","unstructured":"Schi\u00f8tt CR, Stenderup A. Terramycin, aureomycin and chloromycetin dependent bacteria isolated from patients. Ugeskr Laeg. 1954;116:56\u20139.","journal-title":"Ugeskr Laeg"},{"key":"963_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3181\/00379727-74-18059","volume":"74","author":"TM Gocke","year":"1950","unstructured":"Gocke TM, Finland M. Development of chloramphenicol-resistant and chloramphenicol-dependent variants of a strain of Klebsiella pneumoniae. Proc Soc Exp Biol Med. 1950;74:824\u20139.","journal-title":"Proc Soc Exp Biol Med"},{"key":"963_CR17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF00332638","volume":"187","author":"ER Dabbs","year":"1982","unstructured":"Dabbs ER. Three additional loci of rifampicin dependence in Escherichia coli. Mol Gen Genet. 1982;187:519\u201322.","journal-title":"Mol Gen Genet"},{"key":"963_CR18","first-page":"40","volume":"14","author":"M Zhong","year":"2010","unstructured":"Zhong M, Zhang X, Wang Y, Zhang C, Chen G, Hu P, et al. An interesting case of rifampicin-dependent\/-enhanced multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2010;14:40\u20134.","journal-title":"Int J Tuberc Lung Dis"},{"key":"963_CR19","first-page":"575","volume":"135","author":"BA Maguire","year":"1989","unstructured":"Maguire BA, Deaves JK, Wild DG. Some properties of two erythromycin-dependent strains of Escherichia coli. J Gen Microbiol. 1989;135:575\u201381.","journal-title":"J Gen Microbiol"},{"key":"963_CR20","first-page":"216","volume":"27","author":"S-Y Ko","year":"2007","unstructured":"Ko S-Y, Chung H-J, Sung H-S, Kim M-N. Emergence of beta-lactam-dependent Bacillus cereus associated with prolonged treatment with cefepime in a neutropenic patient. Korean J Lab Med. 2007;27:216\u201320.","journal-title":"Korean J Lab Med"},{"key":"963_CR21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkaa482","volume":"76","author":"DJ Wolter","year":"2020","unstructured":"Wolter DJ, Scott A, Armbruster CR, Whittington D, Edgar JS, Qin X, et al. Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient. J Antimicrob Chemother. 2020;76:616\u201325.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/fmb-2020-0068","volume":"15","author":"VA Garc\u00eda-Angulo","year":"2020","unstructured":"Garc\u00eda-Angulo VA, Herve B, Melo J, Sanhueza C, la Fuente SD, Aguirre LL, et al. Isolation and first draft genome sequence of a linezolid-dependent Staphylococcus aureus clinical strain. Future Microbiol. 2020;15:1123\u20139.","journal-title":"Future Microbiol"},{"key":"963_CR23","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1128\/AAC.01115-07","volume":"51","author":"JS Hawley","year":"2007","unstructured":"Hawley JS, Murray CK, Jorgensen JH. Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Antimicrob Agents Chemother. 2007;51:4529\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR24","doi-asserted-by":"crossref","first-page":"2000704","DOI":"10.1002\/advs.202000704","volume":"7","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Lu J, Han M-L, Jiang X, Azad MAK, Patil NA, et al. Polymyxins bind to the cell surface of unculturable acinetobacter baumannii and cause unique dependent resistance. Adv Sci. 2020;7:2000704.","journal-title":"Adv Sci"},{"key":"963_CR25","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1128\/JVI.78.22.12428-12437.2004","volume":"78","author":"CE Baldwin","year":"2004","unstructured":"Baldwin CE, Sanders RW, Deng Y, Jurriaans S, Lange JM, Lu M, et al. Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor. J Virol. 2004;78:12428\u201337.","journal-title":"J Virol"},{"key":"963_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/AAC.00946-13","volume":"58","author":"C Rueda","year":"2014","unstructured":"Rueda C, Cuenca-Estrella M, Zaragoza O. Paradoxical growth of candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence. Antimicrob Agents Chemother. 2014;58:1071\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/155210a0","volume":"155","author":"WS Miller","year":"1945","unstructured":"Miller WS, Green CA, Kitchen H. Biphasic action of penicillin and other sulphonamide similarity. Nature. 1945;155:210\u20131.","journal-title":"Nature"},{"key":"963_CR28","first-page":"97","volume":"13","author":"M Wainwright","year":"1991","unstructured":"Wainwright M. Streptomycin: discovery and resultant controversy. Hist Philos Life Sci. 1991;13:97\u2013124.","journal-title":"Hist Philos Life Sci"},{"key":"963_CR29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.106.2759.476","volume":"106","author":"K Vennesland","year":"1947","unstructured":"Vennesland K, Ebert RH, Bloch RG. The demonstration of naturally-occurring streptomycin-resistant variants in the human strain of Tubercle Bacillus H-37RV. Science. 1947;106:476\u20137.","journal-title":"Science"},{"key":"963_CR30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/jb.57.5.565-572.1949","volume":"57","author":"HB Newcombe","year":"1949","unstructured":"Newcombe HB, Hawirko R. Spontaneous mutation to streptomycin resistance and dependence in Escherichia coli. J Bacteriol. 1949;57:565\u201372.","journal-title":"J Bacteriol"},{"key":"963_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3181\/00379727-64-15753","volume":"64","author":"HR Curran","year":"1947","unstructured":"Curran HR, Evans FR. Stimulation of sporogenic and nonsporogenic bacteria by traces of penicillin or streptomycin. Proc Soc Exp Biol Med. 1947;64:231\u20133.","journal-title":"Proc Soc Exp Biol Med"},{"key":"963_CR32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00272909","volume":"184","author":"ER Dabbs","year":"1981","unstructured":"Dabbs ER, Looman K. An antibiotic dependent conditional lethal mutant with a lesion affecting transcription and translation. Mol Gen Genet. 1981;184:224\u20139.","journal-title":"Mol Gen Genet"},{"key":"963_CR33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/jb.139.3.1072-1074.1979","volume":"139","author":"ER Dabbs","year":"1979","unstructured":"Dabbs ER. New tool for studying interactions of components of RNA polymerase: rifampin dependent mutants. J Bacteriol. 1979;139:1072.","journal-title":"J Bacteriol"},{"key":"963_CR34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/jb.137.3.1452-1455.1979","volume":"137","author":"TM Henkin","year":"1979","unstructured":"Henkin TM, Campbell KM, Chambliss GH. Spectinomycin dependence in Bacillus subtilis. J Bacteriol. 1979;137:1452\u20135.","journal-title":"J Bacteriol"},{"key":"963_CR35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00268768","volume":"183","author":"Y Pai","year":"1981","unstructured":"Pai Y, Dabbs ER. Conditional lethal mutants of Bacillus subtilis dependent on kasugamycin for growth. Molec Gen Genet. 1981;183:478\u201383.","journal-title":"Molec Gen Genet"},{"key":"963_CR36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00267438","volume":"177","author":"ER Dabbs","year":"1980","unstructured":"Dabbs ER. The ribosomal components responsible for kasugamycin dependence, and its suppression, in a mutant of Escherichia coli. Molec Gen Genet. 1980;177:271\u20136.","journal-title":"Molec Gen Genet"},{"key":"963_CR37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-1033.1980.tb07222.x","volume":"112","author":"AR Subramanian","year":"1980","unstructured":"Subramanian AR, Dabbs ER. Functional studies on ribosomes lacking protein L1 from mutant Escherichia coli. Eur J Biochem. 1980;112:425\u201330.","journal-title":"Eur J Biochem"},{"key":"963_CR38","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ncomms2346","volume":"4","author":"H Demirci","year":"2013","unstructured":"Demirci H, Murphy F, Murphy E, Gregory ST, Dahlberg AE, Jogl G. A structural basis for streptomycin-induced misreading of the genetic code. Nat Commun. 2013;4:1355.","journal-title":"Nat Commun"},{"key":"963_CR39","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.166.3910.1282","volume":"166","author":"EA Birge","year":"1969","unstructured":"Birge EA, Kurland CG. Altered ribosomal protein in streptomycin-dependent Escherichia coli. Science. 1969;166:1282\u20134.","journal-title":"Science"},{"key":"963_CR40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00267704","volume":"109","author":"EA Birge","year":"1970","unstructured":"Birge EA, Kuriland CG. Reversion of a streptomycin-dependent strain of Escherichia coli. Molec Gen Genet. 1970;109:356\u201369.","journal-title":"Molec Gen Genet"},{"key":"963_CR41","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/j.1460-2075.1984.tb02176.x","volume":"3","author":"T Ruusala","year":"1984","unstructured":"Ruusala T, Andersson D, Ehrenberg M, Kurland CG. Hyper-accurate ribosomes inhibit growth. EMBO J. 1984;3:2575\u201380.","journal-title":"EMBO J"},{"key":"963_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00331638","volume":"202","author":"I Diaz","year":"1986","unstructured":"Diaz I, Ehrenberg M, Kurland CG. How do combinations of rpsL- and miaA- generate streptomycin dependence? Mol Gen Genet. 1986;202:207\u201311.","journal-title":"Mol Gen Genet"},{"key":"963_CR43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00292717","volume":"231","author":"L Boe","year":"1992","unstructured":"Boe L. Translational errors as the cause of mutations in Escherichia coli. Molec Gen Genet. 1992;231:469\u201371.","journal-title":"Molec Gen Genet"},{"key":"963_CR44","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1128\/jb.170.8.3756-3760.1988","volume":"170","author":"M Fax\u00e9n","year":"1988","unstructured":"Fax\u00e9n M, Kirsebom LA, Isaksson LA. Is efficiency of suppressor tRNAs controlled at the level of ribosomal proofreading in vivo? J Bacteriol. 1988;170:3756\u201360.","journal-title":"J Bacteriol"},{"key":"963_CR45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00280294","volume":"230","author":"J Sipley","year":"1991","unstructured":"Sipley J, Dunn J, Goldman E. Bacteriophage T7 morphogenesis and gene 10 frameshifting in Escherichia coli showing different degrees of ribosomal fidelity. Mol Gen Genet. 1991;230:376\u201384.","journal-title":"Mol Gen Genet"},{"key":"963_CR46","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1073\/pnas.90.6.2315","volume":"90","author":"J Sipley","year":"1993","unstructured":"Sipley J, Goldman E. Increased ribosomal accuracy increases a programmed translational frameshift in Escherichia coli. Proc Natl Acad Sci U S A. 1993;90:2315\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"963_CR47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00327186","volume":"210","author":"A Merryweather","year":"1987","unstructured":"Merryweather A, Bernander R, Nordstr\u00f6m K. Direct selection for the exchange of alleles between a plasmid and the Escherichia coli chromosome. Mol Gen Genet. 1987;210:381\u20134.","journal-title":"Mol Gen Genet"},{"key":"963_CR48","doi-asserted-by":"crossref","first-page":"e0142321","DOI":"10.1128\/mBio.01423-21","volume":"12","author":"B Wang","year":"2021","unstructured":"Wang B, Svetlov V, Wolf YI, Koonin EV, Nudler E, Artsimovitch I. Allosteric activation of SARS-CoV-2 RNA-dependent RNA polymerase by remdesivir triphosphate and other phosphorylated nucleotides. MBio. 2021;12:e0142321.","journal-title":"MBio"},{"key":"963_CR49","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41589-018-0063-y","volume":"14","author":"IL Volkov","year":"2018","unstructured":"Volkov IL, Lind\u00e9n M, Aguirre Rivera J, Ieong K-W, Metelev M, Elf J, et al. tRNA tracking for direct measurements of protein synthesis kinetics in live cells. Nat Chem Biol. 2018;14:618\u201326.","journal-title":"Nat Chem Biol"},{"key":"963_CR50","doi-asserted-by":"crossref","first-page":"637656","DOI":"10.3389\/fmicb.2021.637656","volume":"12","author":"AM Turner","year":"2021","unstructured":"Turner AM, Lee JYH, Gorrie CL, Howden BP, Carter GP. Genomic insights into last-line antimicrobial resistance in multidrug-resistant Staphylococcus and vancomycin-resistant Enterococcus. Front Microbiol. 2021;12:637656.","journal-title":"Front Microbiol"},{"key":"963_CR51","volume":"168","author":"EVK Ledger","year":"2022","unstructured":"Ledger EVK, Sabnis A, Edwards AM. Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort. Microbiology (Reading). 2022;168: 001136.","journal-title":"Microbiology (Reading)"},{"key":"963_CR52","first-page":"694","volume":"19","author":"FR Bruniera","year":"2015","unstructured":"Bruniera FR, Ferreira FM, Saviolli LRM, Bacci MR, Feder D, da Luz Gon\u00e7alves Pedreira M, et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19:694\u2013700.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"963_CR53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","volume":"29","author":"PJ Stogios","year":"2020","unstructured":"Stogios PJ, Savchenko A. Molecular mechanisms of vancomycin resistance. Protein Sci. 2020;29:654\u201369.","journal-title":"Protein Sci"},{"key":"963_CR54","doi-asserted-by":"crossref","first-page":"e00102","DOI":"10.1128\/mSphere.00102-20","volume":"5","author":"Y Hashimoto","year":"2020","unstructured":"Hashimoto Y, Kita I, Suzuki M, Hirakawa H, Ohtaki H, Tomita H. First report of the local spread of vancomycin-resistant enterococci ascribed to the interspecies transmission of a vanA gene cluster-carrying linear plasmid. mSphere. 2020;5:e00102-e120.","journal-title":"mSphere."},{"key":"963_CR55","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1128\/JCM.00211-16","volume":"54","author":"ML Faron","year":"2016","unstructured":"Faron ML, Ledeboer NA, Buchan BW. Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant Enterococcus in the health care setting. J Clin Microbiol. 2016;54:2436\u201347.","journal-title":"J Clin Microbiol"},{"key":"963_CR56","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/jb.174.8.2582-2591.1992","volume":"174","author":"M Arthur","year":"1992","unstructured":"Arthur M, Molinas C, Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 1992;174:2582\u201391.","journal-title":"J Bacteriol"},{"key":"963_CR57","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.bbagen.2017.05.011","volume":"1861","author":"CS Hughes","year":"2017","unstructured":"Hughes CS, Longo E, Phillips-Jones MK, Hussain R. Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci. Biochim Biophys Acta Gen Subj. 2017;1861:1951\u20139.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"963_CR58","doi-asserted-by":"crossref","first-page":"46180","DOI":"10.1038\/srep46180","volume":"7","author":"MK Phillips-Jones","year":"2017","unstructured":"Phillips-Jones MK, Channell G, Kelsall CJ, Hughes CS, Ashcroft AE, Patching SG, et al. Hydrodynamics of the VanA-type VanS histidine kinase: an extended solution conformation and first evidence for interactions with vancomycin. Sci Rep. 2017;7:46180.","journal-title":"Sci Rep"},{"key":"963_CR59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1365-2958.1998.01114.x","volume":"30","author":"M Arthur","year":"1998","unstructured":"Arthur M, Depardieu F, Cabani\u00e9 L, Reynolds P, Courvalin P. Requirement of the VanY and VanX D, D-peptidases for glycopeptide resistance in enterococci. Mol Microbiol. 1998;30:819\u201330.","journal-title":"Mol Microbiol"},{"key":"963_CR60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/AAC.46.1.95-100.2002","volume":"46","author":"O-H Amb\u00far","year":"2002","unstructured":"Amb\u00far O-H, Reynolds PE, Arias CA. d-Ala:d-Ala ligase gene flanking the vanC cluster: evidence for presence of three ligase genes in vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother. 2002;46:95\u2013100.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR61","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.44.6.1660-1666.2000","volume":"44","author":"CA Arias","year":"2000","unstructured":"Arias CA, Courvalin P, Reynolds PE. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother. 2000;44:1660\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/antibiotics11020258","volume":"11","author":"TA Eubank","year":"2022","unstructured":"Eubank TA, Gonzales-Luna AJ, Hurdle JG, Garey KW. Genetic mechanisms of vancomycin resistance in Clostridioides difficile: a systematic review. Antibiotics (Basel). 2022;11:258.","journal-title":"Antibiotics (Basel)"},{"key":"963_CR63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ng1830","volume":"38","author":"M Sebaihia","year":"2006","unstructured":"Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet. 2006;38:779\u201386.","journal-title":"Nat Genet"},{"key":"963_CR64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkz513","volume":"75","author":"W-J Shen","year":"2020","unstructured":"Shen W-J, Deshpande A, Hevener KE, Endres BT, Garey KW, Palmer KL, et al. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates. J Antimicrob Chemother. 2020;75:859\u201367.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR65","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jac\/33.5.1066","volume":"33","author":"N Woodford","year":"1994","unstructured":"Woodford N, Johnson AP, Morrison D, Hastings JG, Elliott TS, Worthington A, et al. Vancomycin-dependent enterococci in the United Kingdom. J Antimicrob Chemother. 1994;33:1066.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR66","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/14.3.765","volume":"14","author":"A Majumdar","year":"1999","unstructured":"Majumdar A, Lipkin GW, Eliott TS, Wheeler DC. Vancomycin-dependent enterococci in a uraemic patient with sclerosing peritonitis. Nephrol Dial Transplant. 1999;14:765\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"963_CR67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1472-765X.2005.01722.x","volume":"41","author":"K Tanimoto","year":"2005","unstructured":"Tanimoto K, Nomura T, Hamatani H, Xiao Y-H, Ike Y. A vancomycin-dependent VanA-type Enterococcus faecalis strain isolated in Japan from chicken imported from China. Lett Appl Microbiol. 2005;41:157\u201362.","journal-title":"Lett Appl Microbiol"},{"key":"963_CR68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.43.1.41","volume":"43","author":"F Van Bambeke","year":"1999","unstructured":"Van Bambeke F, Chauvel M, Reynolds PE, Fraimow HS, Courvalin P. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob Agents Chemother. 1999;43:41\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.patbio.2008.07.017","volume":"57","author":"F Bert","year":"2009","unstructured":"Bert F, Leflon-Guibout V, Le Grand J, Bourdon N, Nicolas-Chanoine M-H. Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review. Pathol Biol (Paris). 2009;57:56\u201360.","journal-title":"Pathol Biol (Paris)"},{"key":"963_CR70","doi-asserted-by":"crossref","first-page":"e00059","DOI":"10.1128\/genomeA.00059-16","volume":"4","author":"M Blaschitz","year":"2016","unstructured":"Blaschitz M, Lepuschitz S, Wagner L, Allerberger F, Indra A, Ruppitsch W, et al. Draft genome sequence of a vancomycin-resistant and vancomycin-dependent Enterococcus faecium isolate. Genome Announc. 2016;4:e00059-e116.","journal-title":"Genome Announc"},{"key":"963_CR71","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/jcm.33.10.2770-2773.1995","volume":"33","author":"LL Dever","year":"1995","unstructured":"Dever LL, Smith SM, Handwerger S, Eng RH. Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol. 1995;33:2770\u20133.","journal-title":"J Clin Microbiol"},{"key":"963_CR72","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/clinids\/20.3.712","volume":"20","author":"M Green","year":"1995","unstructured":"Green M, Shlaes JH, Barbadora K, Shlaes DM. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis. 1995;20:712\u20134.","journal-title":"Clin Infect Dis"},{"key":"963_CR73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijantimicag.2007.08.022","volume":"31","author":"S Huhulescu","year":"2008","unstructured":"Huhulescu S, Schmid D, Mayer B, Stadlbauer S, Wewalka G, Allerberger F, et al. Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007. Int J Antimicrob Agents. 2008;31:86\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"963_CR74","first-page":"299","volume":"29","author":"K Hwang","year":"2009","unstructured":"Hwang K, Sung H, Namgoong S, Yoon NS, Kim M-N. Microbiological and epidemiological characteristics of vancomycin-dependent enterococci. Korean J Lab Med. 2009;29:299\u2013306.","journal-title":"Korean J Lab Med"},{"key":"963_CR75","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0100-879X2011007500006","volume":"44","author":"G Kerbauy","year":"2011","unstructured":"Kerbauy G, Perugini MRE, Yamauchi LM, Yamada-Ogatta SF. Vancomycin-dependent Enterococcus faecium vanA: characterization of the first case isolated in a university hospital in Brazil. Braz J Med Biol Res. 2011;44:253\u20137.","journal-title":"Braz J Med Biol Res"},{"key":"963_CR76","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1086\/313456","volume":"29","author":"BD Kirkpatrick","year":"1999","unstructured":"Kirkpatrick BD, Harrington SM, Smith D, Marcellus D, Miller C, Dick J, et al. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis. 1999;29:1268\u201373.","journal-title":"Clin Infect Dis"},{"key":"963_CR77","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jmii.2016.08.007","volume":"50","author":"S-F Kuo","year":"2017","unstructured":"Kuo S-F, Huang S-P, Lee C-H. Vancomycin-dependent Enterococcus faecium can easily be obscured. J Microbiol Immunol Infect. 2017;50:926\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"963_CR78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.meegid.2017.05.002","volume":"52","author":"SL Mitchell","year":"2017","unstructured":"Mitchell SL, Mattei LM, Alby K. Whole genome characterization of a naturally occurring vancomycin-dependent Enterococcus faecium from a patient with bacteremia. Infect Genet Evol. 2017;52:96\u20139.","journal-title":"Infect Genet Evol"},{"key":"963_CR79","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.00034-09","volume":"53","author":"A San Millan","year":"2009","unstructured":"San Millan A, Depardieu F, Godreuil S, Courvalin P. VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycin. Antimicrob Agents Chemother. 2009;53:1974\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR80","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/109.4.399","volume":"109","author":"LH Sng","year":"1998","unstructured":"Sng LH, Cornish N, Knapp CC, Ludwig MD, Hall GS, Washington JA. Antimicrobial susceptibility testing of a clinical isolate of vancomycin-dependent enterococcus using D-alanine-D-alanine as a growth supplement. Am J Clin Pathol. 1998;109:399\u2013403.","journal-title":"Am J Clin Pathol"},{"key":"963_CR81","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jac\/40.5.734","volume":"40","author":"B Stewart","year":"1997","unstructured":"Stewart B, Hall L, Duke B, Ball D. Vancomycin-dependent enterococci: curious phenomenon or serious threat? J Antimicrob Chemother. 1997;40:734\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR82","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pathol.2018.11.012","volume":"51","author":"V Sukumaran","year":"2019","unstructured":"Sukumaran V, Cosh J, Thammavong A, Kennedy K, Ong CW. Vancomycin dependent Enterococcus: an unusual mutant? Pathology. 2019;51:318\u201320.","journal-title":"Pathology"},{"key":"963_CR83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0255-0857.76531","volume":"29","author":"RA Swann","year":"2011","unstructured":"Swann RA, Bhattacharya S. Vancomycin-dependent Enterococcus. Indian J Med Microbiol. 2011;29:71\u20132.","journal-title":"Indian J Med Microbiol"},{"key":"963_CR84","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3201\/eid1007.030993","volume":"10","author":"PA Tambyah","year":"2004","unstructured":"Tambyah PA, Marx JA, Maki DG. Nosocomial infection with vancomycin-dependent enterococci. Emerg Infect Dis. 2004;10:1277\u201381.","journal-title":"Emerg Infect Dis"},{"key":"963_CR85","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00005373-200004000-00035","volume":"48","author":"CJ Yowler","year":"2000","unstructured":"Yowler CJ, Blinkhorn RJ, Fratianne RB. Vancomycin-dependent Enterococcal strains: case report and review. J Trauma. 2000;48:783\u20135.","journal-title":"J Trauma"},{"key":"963_CR86","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.39.4.830","volume":"39","author":"A Rosato","year":"1995","unstructured":"Rosato A, Pierre J, Billot-Klein D, Buu-Hoi A, Gutmann L. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother. 1995;39:830\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR87","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JB.00613-10","volume":"192","author":"D Meziane-Cherif","year":"2010","unstructured":"Meziane-Cherif D, Saul FA, Moubareck C, Weber P, Haouz A, Courvalin P, et al. Molecular basis of vancomycin dependence in VanA-type Staphylococcus aureus VRSA-9. J Bacteriol. 2010;192:5465\u201371.","journal-title":"J Bacteriol"},{"key":"963_CR88","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1128\/AAC.00454-12","volume":"56","author":"B P\u00e9richon","year":"2012","unstructured":"P\u00e9richon B, Courvalin P. Staphylococcus aureus VRSA-11B is a constitutive vancomycin-resistant mutant of vancomycin-dependent VRSA-11A. Antimicrob Agents Chemother. 2012;56:4693\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2958.1997.4401812.x","volume":"25","author":"M Baptista","year":"1997","unstructured":"Baptista M, Depardieu F, Reynolds P, Courvalin P, Arthur M. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol. 1997;25:93\u2013105.","journal-title":"Mol Microbiol"},{"key":"963_CR90","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/AAC.00338-09","volume":"53","author":"C Moubareck","year":"2009","unstructured":"Moubareck C, Meziane-Cherif D, Courvalin P, P\u00e9richon B. VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth. Antimicrob Agents Chemother. 2009;53:3657\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR91","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1128\/AAC.41.6.1409","volume":"41","author":"F Sifaoui","year":"1997","unstructured":"Sifaoui F, Gutmann L. Vancomycin dependence in a vanA-producing Enterococcus avium strain with a nonsense mutation in the natural D-Ala-D-Ala ligase gene. Antimicrob Agents Chemother. 1997;41:1409.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0255-0857.108747","volume":"31","author":"T Banerjee","year":"2013","unstructured":"Banerjee T, Anupurba S. Isolation and characterization of the first vancomycin-dependent Enterococcus from India. Indian J Med Microbiol. 2013;31:91\u20132.","journal-title":"Indian J Med Microbiol"},{"key":"963_CR93","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2958.2005.04706.x","volume":"57","author":"F Depardieu","year":"2005","unstructured":"Depardieu F, Courvalin P, Kolb A. Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524. Mol Microbiol. 2005;57:550\u201364.","journal-title":"Mol Microbiol"},{"key":"963_CR94","first-page":"1781","volume":"31","author":"AM Slee","year":"1987","unstructured":"Slee AM, Wuonola MA, McRipley RJ, Zajac I, Zawada MJ, Bartholomew PT, et al. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrobial Agents Chemother. 1987;31:1781.","journal-title":"Antimicrobial Agents Chemother."},{"key":"963_CR95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1469-0691.2001.00061.x","volume":"7","author":"E Bouza","year":"2001","unstructured":"Bouza E, Mu\u00f1oz P. Linezolid: pharmacokinetic characteristics and clinical studies. Clin Microbiol Infect. 2001;7:75\u201382.","journal-title":"Clin Microbiol Infect"},{"key":"963_CR96","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","volume":"12","author":"SMR Hashemian","year":"2018","unstructured":"Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther. 2018;12:1759\u201367.","journal-title":"Drug Des Devel Ther"},{"key":"963_CR97","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/AAC.41.10.2127","volume":"41","author":"AH Lin","year":"1997","unstructured":"Lin AH, Murray RW, Vidmar TJ, Marotti KR. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother. 1997;41:2127\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR98","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","volume":"42","author":"SM Swaney","year":"1998","unstructured":"Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998;42:3251\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR99","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm800379d","volume":"51","author":"JA Ippolito","year":"2008","unstructured":"Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, et al. Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J Med Chem. 2008;51:3353\u20136.","journal-title":"J Med Chem"},{"key":"963_CR100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2007.04.005","volume":"26","author":"KL Leach","year":"2007","unstructured":"Leach KL, Swaney SM, Colca JR, McDonald WG, Blinn JR, Thomasco LM, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell. 2007;26:393\u2013402.","journal-title":"Mol Cell"},{"key":"963_CR101","doi-asserted-by":"crossref","first-page":"13339","DOI":"10.1073\/pnas.0804276105","volume":"105","author":"DN Wilson","year":"2008","unstructured":"Wilson DN, Schluenzen F, Harms JM, Starosta AL, Connell SR, Fucini P. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc Natl Acad Sci U S A. 2008;105:13339\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"963_CR102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","volume":"40","author":"JK Bender","year":"2018","unstructured":"Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updates. 2018;40:25\u201339.","journal-title":"Drug Resist Updates"},{"key":"963_CR103","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/jac\/dkac263","volume":"77","author":"A Brenciani","year":"2022","unstructured":"Brenciani A, Morroni G, Schwarz S, Giovanetti E. Oxazolidinones: mechanisms of resistance and mobile genetic elements involved. J Antimicrob Chemother. 2022;77:2596\u2013621.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR104","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.05702-11","volume":"56","author":"KS Long","year":"2012","unstructured":"Long KS, Vester B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother. 2012;56:603\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.resmic.2017.12.003","volume":"169","author":"B Vester","year":"2018","unstructured":"Vester B. The cfr and cfr-like multiple resistance genes. Res Microbiol. 2018;169:61\u20136.","journal-title":"Res Microbiol"},{"key":"963_CR106","first-page":"9274","volume":"24","author":"B-G Liu","year":"2020","unstructured":"Liu B-G, Yuan X-L, He D-D, Hu G-Z, Miao M-S, Xu E-P. Research progress on the oxazolidinone drug linezolid resistance. Eur Rev Med Pharmacol Sci. 2020;24:9274\u201381.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"963_CR107","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/jac\/dkv116","volume":"70","author":"Y Wang","year":"2015","unstructured":"Wang Y, Lv Y, Cai J, Schwarz S, Cui L, Hu Z, et al. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother. 2015;70:2182\u201390.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR108","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1128\/AAC.01729-10","volume":"55","author":"DJ Farrell","year":"2011","unstructured":"Farrell DJ, Mendes RE, Ross JE, Sader HS, Jones RN. LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States. Antimicrob Agents Chemother. 2011;55:3684\u201390.","journal-title":"Antimicrob Agents Chemother"},{"issue":"650","key":"963_CR109","first-page":"e1","volume":"21","author":"I L\u00f3pez-Hern\u00e1ndez","year":"2015","unstructured":"L\u00f3pez-Hern\u00e1ndez I, Delgado Valverde M, Batista D\u00edaz N, Pascual A. First report of linezolid dependence in methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2015;21(650):e1-4.","journal-title":"Clin Microbiol Infect"},{"key":"963_CR110","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1128\/AAC.02835-14","volume":"58","author":"S Kokkori","year":"2014","unstructured":"Kokkori S, Apostolidi M, Tsakris A, Pournaras S, Stathopoulos C, Dinos G. Linezolid-dependent function and structure adaptation of ribosomes in a Staphylococcus epidermidis strain exhibiting linezolid dependence. Antimicrob Agents Chemother. 2014;58:4651\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/EBC20160057","volume":"61","author":"S Hernando-Amado","year":"2017","unstructured":"Hernando-Amado S, Sanz-Garc\u00eda F, Blanco P, Mart\u00ednez JL. Fitness costs associated with the acquisition of antibiotic resistance. Essays Biochem. 2017;61:37\u201348.","journal-title":"Essays Biochem"},{"key":"963_CR112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/eva.12196","volume":"8","author":"AH Melnyk","year":"2015","unstructured":"Melnyk AH, Wong A, Kassen R. The fitness costs of antibiotic resistance mutations. Evol Appl. 2015;8:273\u201383.","journal-title":"Evol Appl"},{"key":"963_CR113","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dkx524","volume":"73","author":"F Layer","year":"2018","unstructured":"Layer F, Vourli S, Karavasilis V, Strommenger B, Dafopoulou K, Tsakris A, et al. Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals. J Antimicrob Chemother. 2018;73:1181\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR114","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1185\/03007995.2015.1018989","volume":"31","author":"AZ Bialvaei","year":"2015","unstructured":"Bialvaei AZ, Samadi KH. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31:707\u201321.","journal-title":"Curr Med Res Opin"},{"key":"963_CR115","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","volume":"9","author":"MAE-G El-Sayed Ahmed","year":"2020","unstructured":"El-Sayed Ahmed MAE-G, Zhong L-L, Shen C, Yang Y, Doi Y, Tian G-B. Colistin and its role in the Era of antibiotic resistance: an extended review (2000\u20132019). Emerg Microbes Infect. 2020;9:868\u201385.","journal-title":"Emerg Microbes Infect."},{"key":"963_CR116","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6:589\u2013601.","journal-title":"Lancet Infect Dis"},{"key":"963_CR117","first-page":"157","volume":"47","author":"T Loho","year":"2015","unstructured":"Loho T, Dharmayanti A. Colistin: an antibiotic and its role in multiresistant Gram-negative infections. Acta Med Indones. 2015;47:157\u201368.","journal-title":"Acta Med Indones"},{"key":"963_CR118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-030-16373-0_4","volume":"1145","author":"Z Li","year":"2019","unstructured":"Li Z, Velkov T. Polymyxins: mode of action. Adv Exp Med Biol. 2019;1145:37\u201354.","journal-title":"Adv Exp Med Biol"},{"key":"963_CR119","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s40262-017-0561-1","volume":"56","author":"N Gr\u00e9goire","year":"2017","unstructured":"Gr\u00e9goire N, Aranzana-Climent V, Magr\u00e9ault S, Marchand S, Couet W. Clinical pharmacokinetics and pharmacodynamics of colistin. Clin Pharmacokinet. 2017;56:1441\u201360.","journal-title":"Clin Pharmacokinet"},{"key":"963_CR120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","volume":"5","author":"AO Olaitan","year":"2014","unstructured":"Olaitan AO, Morand S, Rolain J-M. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643.","journal-title":"Front Microbiol"},{"key":"963_CR121","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2958.1998.00757.x","volume":"27","author":"JS Gunn","year":"1998","unstructured":"Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol. 1998;27:1171\u201382.","journal-title":"Mol Microbiol"},{"key":"963_CR122","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-16373-0_5","volume":"1145","author":"JH Moffatt","year":"2019","unstructured":"Moffatt JH, Harper M, Boyce JD. Mechanisms of polymyxin resistance. Adv Exp Med Biol. 2019;1145:55\u201371.","journal-title":"Adv Exp Med Biol"},{"key":"963_CR123","doi-asserted-by":"crossref","first-page":"43111","DOI":"10.1074\/jbc.M106960200","volume":"276","author":"Z Zhou","year":"2001","unstructured":"Zhou Z, Ribeiro AA, Lin S, Cotter RJ, Miller SI, Raetz CR. Lipid A modifications in polymyxin-resistant Salmonella typhimurium: PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation. J Biol Chem. 2001;276:43111\u201321.","journal-title":"J Biol Chem"},{"key":"963_CR124","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.00834-10","volume":"54","author":"JH Moffatt","year":"2010","unstructured":"Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, Seemann T, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54:4971\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12866-021-02250-x","volume":"21","author":"S Liu","year":"2021","unstructured":"Liu S, Fang R, Zhang Y, Chen L, Huang N, Yu K, et al. Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin. BMC Microbiol. 2021;21:208.","journal-title":"BMC Microbiol"},{"key":"963_CR126","doi-asserted-by":"crossref","first-page":"e02033","DOI":"10.1128\/AAC.02033-19","volume":"64","author":"H Puja","year":"2020","unstructured":"Puja H, Bolard A, Nogu\u00e8s A, Pl\u00e9siat P, Jeannot K. The Efflux Pump MexXY\/OprM contributes to the tolerance and acquired resistance of Pseudomonas aeruginosa to Colistin. Antimicrob Agents Chemother. 2020;64:e02033-e2119.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR127","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s11033-021-06307-y","volume":"48","author":"NH Hussein","year":"2021","unstructured":"Hussein NH, Al-Kadmy IMS, Taha BM, Hussein JD. Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review. Mol Biol Rep. 2021;48:2897\u2013907.","journal-title":"Mol Biol Rep"},{"key":"963_CR128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/ijms22020576","volume":"22","author":"S Chamoun","year":"2021","unstructured":"Chamoun S, Welander J, Martis-Thiele M-M, Ntzouni M, Claesson C, Vikstr\u00f6m E, et al. Colistin dependence in extensively drug-resistant acinetobacter baumannii strain is associated with ISAjo2 and ISAba13 insertions and multiple cellular responses. Int J Mol Sci. 2021;22:576.","journal-title":"Int J Mol Sci"},{"key":"963_CR129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijantimicag.2015.07.017","volume":"46","author":"M Garc\u00eda-Quintanilla","year":"2015","unstructured":"Garc\u00eda-Quintanilla M, Carretero-Ledesma M, Moreno-Mart\u00ednez P, Mart\u00edn-Pe\u00f1a R, Pach\u00f3n J, McConnell MJ. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. Int J Antimicrob Agents. 2015;46:696\u2013702.","journal-title":"Int J Antimicrob Agents"},{"key":"963_CR130","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/AAC.02642-13","volume":"58","author":"M Garc\u00eda-Quintanilla","year":"2014","unstructured":"Garc\u00eda-Quintanilla M, Pulido MR, Moreno-Mart\u00ednez P, Mart\u00edn-Pe\u00f1a R, L\u00f3pez-Rojas R, Pach\u00f3n J, et al. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide. Antimicrob Agents Chemother. 2014;58:2972\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"963_CR131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/microorganisms10010058","volume":"10","author":"H Kon","year":"2021","unstructured":"Kon H, Hameir A, Temkin E, Keren-Paz A, Schwartz D, Schechner V, et al. Colistin dependency among colistin-heteroresistant Acinetobacter baumannii isolates. Microorganisms. 2021;10:58.","journal-title":"Microorganisms"},{"key":"963_CR132","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1038\/s41598-017-14609-0","volume":"7","author":"J-Y Lee","year":"2017","unstructured":"Lee J-Y, Chung ES, Ko KS. Transition of colistin dependence into colistin resistance in Acinetobacter baumannii. Sci Rep. 2017;7:14216.","journal-title":"Sci Rep"},{"key":"963_CR133","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ijantimicag.2018.08.002","volume":"52","author":"Y-K Hong","year":"2018","unstructured":"Hong Y-K, Ko KS. Development of colistin dependence in non-baumannii Acinetobacter species. Int J Antimicrob Agents. 2018;52:742\u20133.","journal-title":"Int J Antimicrob Agents"},{"key":"963_CR134","volume":"96","author":"J-Y Lee","year":"2020","unstructured":"Lee J-Y, Hong Y-K, Ko KS. Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2020;96: 114965.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"963_CR135","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/jac\/dkw121","volume":"71","author":"Y-K Hong","year":"2016","unstructured":"Hong Y-K, Lee J-Y, Wi YM, Ko KS. High rate of colistin dependence in Acinetobacter baumannii. J Antimicrob Chemother. 2016;71:2346\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"963_CR136","doi-asserted-by":"crossref","first-page":"1156.e1","DOI":"10.1016\/j.cmi.2019.02.004","volume":"25","author":"J-Y Lee","year":"2019","unstructured":"Lee J-Y, Lee H, Park M, Cha C-J, Shin D, Ko KS. Lytic transglycosylase contributes to the survival of lipooligosaccharide-deficient, colistin-dependent Acinetobacter baumannii. Clin Microbiol Infect. 2019;25:1156.e1-1156.e7.","journal-title":"Clin Microbiol Infect"},{"key":"963_CR137","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jac\/dkv028","volume":"70","author":"V Karavasilis","year":"2015","unstructured":"Karavasilis V, Zarkotou O, Panopoulou M, Kachrimanidou M, Themeli-Digalaki K, Stylianakis A, et al. Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone. J Antimicrob Chemother. 2015;70:1625\u20139.","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-023-00963-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-023-00963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:06:30Z","timestamp":1700237190000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-023-00963-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s12929-023-00963-x","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}